Key references: Neisseria meningitidis prophylaxis in adults treated with eculizumab

  • Hall V, Pai Mangalore R, He S, Stevens K, Trubiano JA, Holmes NE, et al. Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab. Med J Aust 2018;208(11):478–9. https://www.ncbi.nlm.nih.gov/pubmed/29902403
  • McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High risk for invasive meningococcal disease among patients receiving eculizumab (soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep 2017;66(27):734–7. https://www.ncbi.nlm.nih.gov/pubmed/28704351